Want to see ACH full AI Analyst Report?
ACH Stock Chart & Stats
$1.21
-$0.05(-3.97%)
At close: 4:00 PM EDT
$1.21
-$0.05(-3.97%)
Day’s Range― - ―
52-Week Range$0.22 - $5.60
Previous Close$1.21
Volume2.00M
Average Volume (3M)1.50M
Market Cap
$18.07M
Enterprise Value$2.07B
Total Cash (Recent Filing)$7.65M
Total Debt (Recent Filing)$1.78B
Price to Earnings (P/E)―
Beta1.40
Next Earnings
Nov 04, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend Yield0.02%
Share Statistics
EPS (TTM)-3.91
Shares Outstanding76,904,700
10 Day Avg. Volume1,873,785
30 Day Avg. Volume1,500,404
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.47
Price to Sales (P/S)0.08
P/FCF Ratio-0.71
Enterprise Value/Market Cap114.78
Enterprise Value/Revenue0.78
Enterprise Value/Gross Profit1.75
Enterprise Value/Ebitda9.03
Forecast
1Y Price Target
$1.45Price Target Upside19.83% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)0.02
Revenue Forecast (FY)$2.49B
Bulls Say, Bears Say
Bulls Say
Cost Reduction And Debt Maturity ExtensionLarge structural cost reductions can lower the company’s expense base and improve operating leverage if retained. Debt reduction and extended maturities also reduce near-term refinancing pressure, giving management more time to execute its standalone strategy and pursue cash-flow improvement.
Growth In Key Care CategoriesGrowth across sleep, diabetes, ostomy, and urology indicates that the portfolio retains areas of underlying demand despite broader revenue pressure. Continued expansion in these categories could diversify performance, improve capacity utilization, and support a more durable recovery.
Protection Of Tax AttributesPreserving substantial net operating loss carryforwards can protect future tax efficiency if the company returns to profitability. The rights plan reduces the risk that an ownership change limits those attributes, supporting future cash retention and capital deployment flexibility.
Bears Say
Negative Equity And Stressed Capital StructureNegative equity signals a materially weakened capital structure and limits financial flexibility even after debt reduction. It can make future financing more difficult, constrain capital allocation, and leave the company less able to absorb operating setbacks or prolonged underperformance.
Deep Losses And Negative Cash GenerationPersistent net losses combined with negative operating and free cash flow indicate that the current business is consuming cash rather than self-funding operations. Unless cost actions and revenue initiatives reverse this pattern, liquidity needs may remain elevated and constrain investment or debt reduction.
Collections And Accounts Receivable PressureCollection disruption and deteriorating receivables weaken the conversion of reported revenue into cash and make quarterly performance less predictable. Continued audit resolution requires resources and could delay cash-flow recovery, increasing execution risk while the company operates with tight liquidity.
Accendra Health News
ACH FAQ
What was Accendra Health’s price range in the past 12 months?
Accendra Health lowest stock price was $0.22 and its highest was $5.60 in the past 12 months.
What is Accendra Health’s market cap?
Accendra Health’s market cap is $18.07M.
When is Accendra Health’s upcoming earnings report date?
Accendra Health’s upcoming earnings report date is Nov 04, 2026 which is in 16 days.
How were Accendra Health’s earnings last quarter?
Accendra Health released its earnings results on Aug 10, 2026. The company reported -$0.19 earnings per share for the quarter, missing the consensus estimate of -$0.084 by -$0.106.
Is Accendra Health overvalued?
According to Wall Street analysts Accendra Health’s price is currently Undervalued.
Does Accendra Health pay dividends?
Accendra Health pays a Quarterly dividend of $0.002 which represents an annual dividend yield of 0.02%. See more information on Accendra Health dividends here
What is Accendra Health’s EPS estimate?
Accendra Health’s EPS estimate is <0.01.
How many shares outstanding does Accendra Health have?
Accendra Health has 76,904,700 shares outstanding.
What happened to Accendra Health’s price movement after its last earnings report?
Accendra Health reported an EPS of -$0.19 in its last earnings report, missing expectations of -$0.084. Following the earnings report the stock price went down -50%.
Which hedge fund is a major shareholder of Accendra Health?
Currently, no hedge funds are holding shares in ACH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Accendra Health
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.
ACH Company Deck
ACH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted meaningful strategic and financial progress — notably >$125M of annualized cost reductions, a successful balance sheet optimization (debt down ~ $400M and extended maturities), improving growth in sleep and diabetes, and commercial wins and operational initiatives positioned to drive late‑2026/2027 upside. However, near‑term performance was impaired by several material operational headwinds: unusually large payor audit activity that depressed collections (≈$10M in Q2, $20M H1), worsening AR and cash pressure, category weakness in respiratory and wound, and later-than-expected timing of cost benefits. Management has clear remediation plans (cost actions, collections fixes, logistics partnerships, asset sales, ATM program) and expects a stronger Q4 and improved 2027, but the near-term mix of execution and cash challenges tempers the positive long‑term narrative.View all ACH earnings summariesACH Stock 12 Month Forecast
Average Price Target
$1.45
▲(19.83% Upside)
Technical Analysis
Ridgetech
―
Akso Health Group Sponsored ADR
―
111
―
Hong Kong Pharma Digital Technology Holdings Ltd.
―
DataMeds AI
―
Ownership Overview
3.81% Insiders
19.28% Mutual Funds
0.11% Other Institutional Investors
63.63% Public Companies and
Individual Investors